Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02616029
Brief Title: Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

First Submitted : November 24, 2015
First Submitted that Met QC Criteria : November 24, 2015
First Posted : November 26, 2015 (Estimate)

Results First Submitted : October 10, 2019
Results First Submitted that Met QC Criteria : October 10, 2019
Results First Posted : November 4, 2019

Last Update Submitted that Met QC Criteria : July 9, 2020
Last Update Posted : July 23, 2020